
Izvēlieties etiķeti
redzama tieši uz flakonaLaboratorijas ziņojums
PDF- Pārbaudīts
- GHK-Cu + KPV Blend 60mg
- Laboratorija
- Analiza Białek
- Datums
- October 2026
- Rezultāts
- 99% purity (GHK-Cu 95.54 mg + KPV 10.91 mg, 50 + 10 mg label)
- Endotoksīni
- 6.88 EU/vial
- Pasūtījuma nr.
- Parole
Neatkarīgi pārbaudīts, ar paroli pārbaudāms tieši laboratorijā.
GHK-Cu + KPV Blend
Healing
- Laboratorijā pārbaudīts · 99% tīrība
- Sūtām no Vācijas
Pasūtījums
- DHL ar izsekošanu
- Diskrēts iepakojums
Īsumā
GHK-Cu + KPV Blend skaitļos
Galvenie rādītāji no mūsu leksikona.
Pilns leksikona ieraksts- Type
- Blend of two tripeptidesGHK-Cu + KPV
- Use
- Subcutaneous injection after reconstitution
- Sizes
- 60 mg1 size in the shop
What studies show
All 7 sources in the lexicon- BioMed Research International
- Journal of Biomaterials Science, Polymer Edition
- Macromolecular Bioscience
Zināšanas
Viss par GHK-Cu + KPV Blend
Detalizēta informācija drīzumā.
Dozēšana
Ielādē dozēšanas informāciju …
Noderēs
Kas jums vēl būs vajadzīgs
Bakteriostatiskais ūdens tiek automātiski pievienots grozam. Šļirces un salvetes - ar vienu klikšķi.
Insulīna šļirces
10 gab. · 5.50 €
Spirta salvetes
50 gab. · 10 €
Cik daudz ūdens?
Vienības uz šļirces jūsu flakona izmēram.
Atvērt kalkulatoru →Are there studies on the GHK-Cu + KPV Blend?
No. As of 26 October 2026 there is no study on the blend, neither on ClinicalTrials.gov nor in PubMed. The only paper naming both peptides is a review of tripeptides in wound healing without its own data on the blend. Only the single components have been studied.
Why these two peptides?
The idea is that the pathways complement each other: GHK-Cu on the side of building and collagen, KPV on the side of calming inflammation. This has not been tested. No study has examined whether the combination does more than either substance alone.
What is known about GHK-Cu in humans?
The best study is a randomised gel trial in diabetic foot ulcers: a median 98.5 percent of the wound area closed, versus 60.8 percent with vehicle gel. Other data come mainly from cosmetics. A recent review calls the clinical evidence sparse, there are no studies on injection.
What is known about KPV?
KPV enters gut and immune cells via the transporter PepT1 and inhibits the inflammation pathway NF-κB there even at nanomolar concentrations. In two colitis models in mice KPV in the drinking water reduced inflammation. In nanoparticles a 12,000-fold lower concentration was enough. In skin cells KPV triggered a calcium signal. There are no human studies.
Which side effects are known?
There are no data for the blend. In the GHK-Cu gel trial 7 percent of ulcers became infected, versus 34 percent with vehicle gel. Human safety data are missing for KPV and for GHK-Cu as an injection. A review of peptides in sport warns that robust safety data are missing for many of these substances.
Is the blend approved?
No. Neither the blend nor GHK-Cu or KPV is approved as a medicine (as of October 2026). ChEMBL lists GHK without a clinical phase and no trial of KPV is registered.
Saistītie
Saistītie produkti
BPC-157
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
4 izmēri
Laboratorijā pārbaudīts
= no 5.2 €/flakons
TB-500 (Thymosin B4)
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
3 izmēri
Laboratorijā pārbaudīts
= no 18.8 €/flakons
TB-500 FRAG
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
1 izmērs
= 24.8 €/flakons
BPC + TB Blend
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
3 izmēri
Laboratorijā pārbaudīts
= no 24.8 €/flakons
GHK-Cu + KPV Blend